Title | Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and Necroptosis. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Tummers, B, Mari, L, Guy, CS, Heckmann, BL, Rodriguez, DA, Rühl, S, Moretti, J, Crawford, JChase, Fitzgerald, P, Kanneganti, T-D, Janke, LJ, Pelletier, S, J Blander, M, Green, DR |
Journal | Immunity |
Volume | 52 |
Issue | 6 |
Pagination | 994-1006.e8 |
Date Published | 2020 Jun 16 |
ISSN | 1097-4180 |
Abstract | Cell death pathways regulate various homeostatic processes. Autoimmune lymphoproliferative syndrome (ALPS) in humans and lymphoproliferative (LPR) disease in mice result from abrogated CD95-induced apoptosis. Because caspase-8 mediates CD95 signaling, we applied genetic approaches to dissect the roles of caspase-8 in cell death and inflammation. Here, we describe oligomerization-deficient Caspase-8 and non-cleavable Caspase-8 mutant mice with defective caspase-8-mediated apoptosis. Although neither mouse developed LPR disease, removal of the necroptosis effector Mlkl from Caspase-8 mice revealed an inflammatory role of caspase-8. Ablation of one allele of Fasl, Fadd, or Ripk1 prevented the pathology of Casp8Mlkl animals. Removing both Fadd alleles from these mice resulted in early lethality prior to post-natal day 15 (P15), which was prevented by co-ablation of either Ripk1 or Caspase-1. Our results suggest an in vivo role of the inflammatory RIPK1-caspase-8-FADD (FADDosome) complex and reveal a FADD-independent inflammatory role of caspase-8 that involves activation of an inflammasome. |
DOI | 10.1016/j.immuni.2020.04.010 |
Alternate Journal | Immunity |
PubMed ID | 32428502 |
PubMed Central ID | PMC7306001 |
Grant List | R01 AI044828 / AI / NIAID NIH HHS / United States R01 AI127658 / AI / NIAID NIH HHS / United States R35 CA231620 / CA / NCI NIH HHS / United States R37 AI044828 / AI / NIAID NIH HHS / United States |